Studies of Cannabinoid-Based Products in ClinicalTrials.gov: A Scoping Review.

ABSTRACT:

Background and objectives

There is increased interest in using cannabinoid-based products for therapeutic purposes. Because of unique regulatory challenges associated with these products, understanding the state of current research is critical to inform future research. The objective of this review was to survey the characteristics of registered studies on ClinicalTrials.gov that describe using cannabinoid-based products as an intervention.

Methods

The scoping review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist and guidance. Eligible studies registered on ClinicalTrials.gov that used cannabinoid-based products as an intervention included those using approved drugs,

SUBMITTER: Haney M 

PROVIDER: S-EPMC12783153 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature